Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abrogate, adenocarcinoma, adenoid, adequacy, Adicet, Affimed, African, ahead, alike, Anixa, Ann, antiviral, Arai, Artiva, aspire, Atara, Beam, biased, BICR, BioNTech, bispecific, Blueprint, bNAb, bystander, captured, Carlsten, Cartesian, Century, chance, clearer, cleavage, clone, Cloud, clustering, CMV, coat, Codiak, cohort, cold, compartment, convalescent, count, counterproductive, CoV, Cox, CT, cystic, cytometric, Cytotherapy, deadliest, deck, deficiency, Deficient, degranulating, degranulation, demarginate, density, deoxyhypusine, depressed, descent, dextrose, diameter, distant, DoHH, driver, drop, dropped, dysfunction, dysfunctional, Emission, ensuing, entirety, epigenetic, ER, eradicated, estrogen, ethnic, Eur, evasion, feeder, Firstly, fold, footprint, frequently, GammaDelta, granzyme, greatest, GzB, hastening, HDACi, headcount, heart, HebeCell, histocompatibility, hormone, hydroxylase, hypoxemia, hypoxemic, IFN, IIb, ImmunityBio, immunomodulation, Immunopharma, inch, inconclusive, indefinitely, induction, infiltration, Interestingly, interferon, intermediate, internet, intracellular, intraperiod, Intriguing, irRECIST, iterative, ix, Jan, Janssen, Jul, kidney, Lancet, lawfully, lay, leasehold, leiomyosarcoma, Lenti, lessening, lessor, Lyell, mantle, marked, MDSC, Mechanistic, memory, men, meningioma, menopausal, Merck, MHC, mid, moderate, Morgan, murine, myeloablative, naive, nanatinostat, narrative, nasopharyngeal, nearby, Nelson, neutralizing, neutrophil, NKMax, noteworthy, Oct, Oncoimmunology, Oncotarget, Onkimmune, orthotopic, outbreak, overnight, paint, pandemic, parallel, PARP, Pathol, pembrolizumab, perforin, picture, platinum, Plonquet, Positron, potion, PR, precipitously, premenopausal, progesterone, prognostic, proliferation, pulmonary, purported, qualification, race, randomized, randomly, reactivity, recast, recipient, RECIST, reconstitute, recreated, regiment, renew, renewal, replication, repressive, resting, retail, Retroviral, Richter, Sarkar, secondarily, SEER, sequelae, shedding, shrink, Sinica, slide, slightly, smallest, software, Sonja, sought, spleen, spread, Stipulation, streamlined, sum, superficial, surprising, susceptible, synergism, thoracic, TNBC, Tomography, Tonn, Treaty, triangle, Triumvira, undesirable, unearned, uniformly, unused, upcoming, upgrade, valganciclovir, vasculature, vii, viii, Virologica, Vycellix, Watanabe, women, Wong, Wrangle, wrongful, Wuhan, xi, xii, Zheng
Removed:
activating, AIA, announcement, CAO, Carolina, Cary, categorize, categorized, Citigroup, codified, cognizant, conversion, defer, depreciated, disruptive, entitle, Fenner, focusing, hospitalization, imputed, issuable, Jaffray, land, lawsuit, lessee, Lynch, matured, Merrill, MLV, NanoCav, North, occupancy, Pierce, Piper, red, Reg, reinvested, remediated, retainer, revalued, RSU, Smith, structural, substantive, tenant, treating, unclear, underwriting, vigorously
Filing tables
Filing exhibits
IBRX similar filings
Filing view
External links
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-233082) and the Registration Statement (Form S-8 No. 333-205942), each pertaining to the 2015 Equity Incentive Plan and 2014 Equity Incentive Plan, and in the Registration Statement on Form S-3 (No. 333-233434) for the registration of common stock, preferred stock, warrants, debt securities and units of our report dated March 25, 2020, with respect to the consolidated financial statements of NantKwest, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2019.
/s/ Ernst & Young LLP
|
Los Angeles, California |
March 25, 2020 |